Precigen, Inc. - 6 Year Dividend History | PGEN
Historical dividend payout and yield for Precigen, Inc. (PGEN) since 2019. The current TTM dividend payout for Precigen, Inc. (PGEN) as of February 21, 2025 is $0.00. The current dividend yield for Precigen, Inc. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.559B |
$0.006B |
|
Precigen Inc. is a biopharmaceutical company. It specialise in the development of gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. The company's transformative therapeutic platforms, including UltraCAR-T(TM), AdenoVerse(TM) cytokine therapies, multifunctional therapeutics and off-the-shelf AdenoVerse(TM) immunotherapies, as well as ActoBio Therapeutics, Exemplar Genetics and Triple-Gene from our subsidiaries. Precigen Inc., formerly known as Intrexon Corporation, is based in Germantown, Maryland.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
